|
|
|
|
|
|
|
|
|
06.05.26 - 00:03
|
Broadwind Announces Strategic Exit From Wind Market With Sale of Abilene Facility, Pivots to Become Pure-Play Precision Manufacturer Supporting Power Generation and Critical Infrastructure Markets; and Withdraws 2026 Financial Guidance (GlobeNewswire EN)
|
|
|
CICERO, Ill., May 05, 2026 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced that on April 30, 2026, the Company's wholly-owned subsidiary, Broadwind Heavy Fabrications, Inc. (“Heavy Fabrications”) entered into a definitive agreement with IES Infrastructure, a wholly-owned subsidiary of IES Holdings, Inc. (NASDAQ: IESC), under which Heavy Fabrications has sold its production facility in Abilene, Texas (the “Facility”), including real property, equipment, machinery and other items, to IES Infrastructure for an aggregate purchase price of up to $19.5 million in cash and non-cash consideration in the form of a below market lease, subject to certain purchase price adjustments....
|
|
|
05.05.26 - 23:54
|
Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions (GlobeNewswire EN)
|
|
|
SAN CARLOS, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that three icovamenib abstracts have been selected for late-breaking poster presentations at the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5–8, 2026 in New Orleans. The presentations include data from icovamenib, the Company's investigational oral menin inhibitor, across both type 1 and type 2 diabetes, highlighting its potential to improve beta cell function and support metabolic health....
|
|
|
|
|
|
|
05.05.26 - 23:39
|
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
RADNOR, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on May 4, 2026, the Compensation Committee of Mineralys' Board of Directors granted inducement stock option awards covering an aggregate of 29,760 shares and inducement restricted stock unit awards covering an aggregate of 22,320 shares of Mineralys common stock to two new non-executive employees....
|
|
|
|
|
|
|
|
|
05.05.26 - 23:18
|
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters′ Option to Purchase Additional Shares (GlobeNewswire EN)
|
|
|
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the closing of its previously announced underwritten public offering. In the offering, Aura sold (i) 46,099,650 shares of common stock, which includes 6,508,650 shares sold upon exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering, and (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase an aggregate of up to 3,800,000 shares of its common stock at an exercise price of $0.00001 per pre-funded warrant. The shares of common stock were sold at a public offering price of $6.00 per share and the pre-funded warrants were sold at a public offering price of $5.99999 per share. The gross proceeds to Aura from the offering were approximately $299.4 million, before deducting underwriting discoun...
|
|
|
|
|
|
|
05.05.26 - 23:15
|
MarketWise, Inc. Declares Regular and Special Dividend on Class A Common Stock totaling $0.45 (GlobeNewswire EN)
|
|
|
BALTIMORE, May 05, 2026 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, announced that its Board of Directors declared a regular quarterly cash dividend and a special cash dividend to holders of Class A common stock of $0.25 and $0.20 per share, respectively, on May 5, 2026. A comparable distribution of $0.25 per common unit has also been approved to holders of MarketWise, LLC common units. The dividend and distribution will be paid on June 25, 2026. The Record Date is May 15, 2026....
|
|
|
05.05.26 - 23:12
|
nVent to Participate in Upcoming Investor Conference (GlobeNewswire EN)
|
|
|
LONDON, May 05, 2026 (GLOBE NEWSWIRE) -- nVent (NYSE: NVT), a global leader in electrical connection and protection solutions, today announced its participation in the Wolfe Research 19th Annual Global Transportation and Industrials Conference on Tuesday, May 19, 2026. Gary Corona, Chief Financial Officer, will present at 8:35 a.m. ET....
|
|
|
05.05.26 - 23:09
|
Diversified Royalty Corp. Announces May 2026 Cash Dividend and Q1 2026 Earnings Release Date (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of May 1, 2026 to May 31, 2026, which is equal to $0.285 per common share on an annualized basis. The dividend will be paid on May 29, 2026 to shareholders of record as of the close of business on May 15, 2026....
|
|
|
|
|
|
|
05.05.26 - 23:06
|
DPM Metals Declares Dividend (GlobeNewswire EN)
|
|
|
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) today announced that its Board of Directors has declared a second quarter dividend of US$0.04 per common share....
|
|